Skip to main content

Table 2 Characteristics at 24 weeks post-antiretroviral therapy (ART) initiation and incomplete adherence (ever with pill count <95% past 24 weeks)

From: Adherence and virologic suppression during the first 24 weeks on antiretroviral therapy among women in Johannesburg, South Africa - a prospective cohort study

Type of exposure

Number (%) in group who had complete adherence

(n = 92)

Number (%) in group who had incomplete adherence

(n = 55)

Univariable odds ratio

(CI 95%)

p value

Quality of life

   

   Good (score 12-23) (95; 65%)

64 (70%)

31 (56%)

1

   Intermediate (score 24-35) (45; 31%)

25 (27%)

20 (36%)

1.6 (0.8-3.4); 0.18

   Poor (score 36-55) (6; 4%)

2 (2%)

4 (8%)

4.1 (0.5-47.2); 0.18*

Life events since ART initiation Moved to a new accommodation

   

   No (113; 77%)

73 (80%)

40 (73%)

1

   Yes (33; 23%)

18 (20%)

15 (27%)

1.5 (0.7-3.4); 0.30

Lost job

   

   No (138; 95%)

88 (97%)

50 (91%)

1

   Yes (8; 5%)

3 (3%)

5 (9%)

2.9 (0.5-19.5); 0.15*

Physically attacked

   

   No (133; 91%)

83 (91%)

50 (91%)

1

   Yes (13; 9%)

8 (8%)

5 (9%)

1.0 (0.3-3.8); 1.00*

Treated badly because of HIV status

   

   No (129; 88%)

79 (87%)

50 (91%)

1

   Yes (17; 12%)

12 (13%)

5 (9%)

0.7 (0.2-2.2); 0.60*

Got divorced/separated

   

   No (118; 80%)

78 (85%)

40 (73%)

1

   Yes (29; 20%)

14 (15%)

15 (27%)

2.1 (0.9-4.8); 0.08

Death of a child since ART initiation

   

   No (140; 96%)

88 (97%)

52 (95%)

1

   Yes (6; 4%)

3 (3%)

3 (5%)

1.7 (0.2-13.1); 0.67*

Death of a family member since ART initiation

   

   No (114; 78%)

72 (79%)

42 (76%)

1

   Yes (32; 22%)

19 (21%)

13 (24%)

1.2 (0.5-2.6); 0.70

Cumulative number of life events

   

   0 (63; 43%)

42 (46%)

21 (38%)

1

   1 (52; 36%)

34 (37%)

18 (33%)

1.1 (0.5-2.3); 0.89

   2 (15; 10%)

7 (8%)

8 (15%)

2.3 (0.7-7.3); 0.15

   ≥3 (16; 11%)

8 (9%)

8 (14%)

2.0 (0.6-6.2); 0.22

  1. ART, antiretroviral therapy
  2. * 2-sided Fisher's exact test